Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EXOC5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ELAVL1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ELL3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TSSK4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TRIT1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | LRRIQ4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZBTB38 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | G6PC3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | PIGN | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | OVCA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |